🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07371091
Starting soon Observational

Post-market Clinical Investigation Plan: Collagen Dura Regeneration Membrane - Repair (DMR)

NCT07371091 · tracked via the Priya Life Science USA tracker
Sponsor
Collagen Matrix
Phase
Observational
Started
2026-07
Last updated
2026-05-29

Condition(s) studied

Repair of Dura Mater

Study summary

Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients with a dural defect requiring repair with a dural substitute as per routine clinical practice * Patient is 18 years or older * Patient of child-bearing potential is not pregnant or nursing * Participant is willing and able to provide consent Exclusion Criteria: * Patients with a known history of hypersensitivity to bovine derived materials * Patients that are non-English speaking * Patients requiring legal representation

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Rush University Medical Center Chicago Illinois
Massachusetts General Hospital Boston Massachusetts

More Collagen Matrix trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07371091 on ClinicalTrials.gov ↗ ← All trials in the USA